AssayIndex
AMB cross-section

AMB by compound

AMB records split by compound, with the index-wide comparison for the same compound beside each one. 18 compounds, 203 records. Cells below n=3 print their raw values instead of a median.

18 compounds203 records
CompoundClassReportsAMB median %Index median %Δ (pp)SpecPass %
GHRP-6Growth-hormone3299.4599.54-0.0999.097
SemaglutideIncretin2498.8798.89-0.0297.0100
TirzepatideIncretin2398.2098.55-0.3597.0100
CJC-1295 (no DAC)Growth-hormone2099.5399.09+0.4498.0100
IpamorelinGrowth-hormone1799.6799.47+0.2099.0100
RetatrutideIncretin1398.1898.37-0.1996.5100
AOD-9604Metabolic1399.4999.29+0.2098.0100
EpitalonShort1299.8999.56+0.3399.0100
PT-141 (Bremelanotide)Melanocortin-receptor1099.8399.38+0.4598.5100
SermorelinGrowth-hormone7 n=799.1199.06+0.0598.0100
SS-31 (Elamipretide)Metabolic7 n=799.5499.53+0.0198.5100
SemaxNeuroactive7 n=799.9299.46+0.4698.5100
Thymosin α1Tissue-repair5 n=599.1199.40-0.2997.5100
TB-500Tissue-repair4 n=499.7699.53+0.2398.5100
OxytocinHypothalamic3 n=399.4499.81-0.3898.5100
L-Glutathione (reduced)Short3 n=399.7999.33+0.4698.5100
MOTS-cMetabolic2 n=2n<399.1398.0100
CJC-1295 with DACGrowth-hormone1 n=1n<398.9597.5100
97.397.898.298.799.299.7100.1GHRP-6GHRP-6: Q1 99.36, median 99.45, Q3 99.67, n=32outlier 98.81n=32SemaglutideSemaglutide: Q1 98.48, median 98.87, Q3 99.33, n=24n=24TirzepatideTirzepatide: Q1 97.81, median 98.20, Q3 98.66, n=23n=23CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 99.32, median 99.53, Q3 99.67, n=20n=20IpamorelinIpamorelin: Q1 99.50, median 99.67, Q3 99.86, n=17n=17RetatrutideRetatrutide: Q1 98.15, median 98.18, Q3 98.31, n=13outlier 97.75outlier 97.86outlier 98.67n=13AOD-9604AOD-9604: Q1 99.39, median 99.49, Q3 99.66, n=13n=13EpitalonEpitalon: Q1 99.39, median 99.89, Q3 99.93, n=12n=12PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.74, median 99.83, Q3 99.93, n=10outlier 99.45n=10SermorelinSermorelin: Q1 99.08, median 99.11, Q3 99.20, n=7outlier 99.38n=7SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 99.44, median 99.54, Q3 99.69, n=7n=7SemaxSemax: Q1 99.79, median 99.92, Q3 99.93, n=7outlier 99.53n=7Thymosin α1Thymosin α1: Q1 99.08, median 99.11, Q3 99.31, n=5outlier 99.93n=5TB-500TB-500: Q1 99.63, median 99.76, Q3 99.86, n=4n=4 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines AMB actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. AmbioPharm, Inc. lists considerably more than the 18 compounds above. Of those 18, 12 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the AMB catalogue at ambiopharm.net →